Estrogen-Mediated, Endothelial Nitric Oxide Synthase–Dependent Mobilization of Bone Marrow–Derived Endothelial Progenitor Cells Contributes to Reendothelialization After Arterial Injury
- 23 December 2003
- journal article
- research article
- Published by Ovid Technologies (Wolters Kluwer Health) in Circulation
- Vol. 108 (25), 3115-3121
- https://doi.org/10.1161/01.cir.0000106906.56972.83
Abstract
Background— We hypothesized that estrogen-induced acceleration of reendothelialization might be mediated in part by effects involving mobilization and incorporation of bone marrow–derived endothelial progenitor cells (EPCs). Methods and Results— Carotid injury was induced in ovariectomized wild-type mice receiving either 17β-estradiol or placebo. Estradiol treatment significantly accelerated reendothelialization of injured arterial segments within 7 days and resulted in a significant reduction of medial thickness 14 and 21 days after the injury. Significant increases in circulating EPCs 3 days after the injury were observed in the estradiol group compared with placebo-treated mice. These data were further supported by fluorescence-activated cell sorting analysis, which disclosed a significant increase in Sca-1/Flk-1–positive cells in estradiol versus control mice. To evaluate the effects of estradiol on bone marrow–derived EPC incorporation at sites of reendothelialization, carotid injury was established in ovariectomized wild-type mice transplanted with bone marrow from transgenic donors expressing β-galactosidase transcriptionally regulated by the Tie-2 promoter. Significantly greater numbers of X-gal–positive cells were observed at reendothelialized areas in the estradiol group 3 days after injury as compared with placebo. Fluorescent immunohistochemistry 14 days after the injury documented a marked increase in cells expressing both β-gal, indicating bone marrow origin and Tie-2 expression, and isolectin B4, also indicating endothelial lineage, in the estradiol group compared with control. In contrast, estradiol did not accelerate reendothelialization or augment EPC mobilization into the peripheral circulation after injury in endothelial nitric oxide synthase–deficient mice (eNOS −/− ). Furthermore, estradiol exhibited direct stimulatory effects on EPC mitogenic and migration activity and inhibited EPC apoptosis. Conclusions— Estradiol accelerates reendothelialization and attenuates medial thickening after carotid injury in part by augmenting mobilization and proliferation of bone marrow–derived EPCs and their incorporation into the recovering endothelium at the site of injury.This publication has 17 references indexed in Scilit:
- Engineering the Response to Vascular InjuryCirculation Research, 2003
- Estrogen Increases Bone Marrow–Derived Endothelial Progenitor Cell Production and Diminishes Neointima FormationCirculation, 2003
- Stromal Cell–Derived Factor-1 Effects on Ex Vivo Expanded Endothelial Progenitor Cell Recruitment for Ischemic NeovascularizationCirculation, 2003
- Bone Marrow–Derived Progenitor Cells Modulate Vascular Reendothelialization and Neointimal FormationArteriosclerosis, Thrombosis, and Vascular Biology, 2002
- Bone marrow–derived stem cells target retinal astrocytes and can promote or inhibit retinal angiogenesisNature Medicine, 2002
- Statin Therapy Accelerates ReendothelializationCirculation, 2002
- Young Adult Bone Marrow–Derived Endothelial Precursor Cells Restore Aging-Impaired Cardiac Angiogenic FunctionCirculation Research, 2002
- HMG-CoA reductase inhibitors (statins) increase endothelial progenitor cells via the PI 3-kinase/Akt pathwayJCI Insight, 2001
- VEGF contributes to postnatal neovascularization by mobilizing bone marrow-derived endothelial progenitor cellsThe EMBO Journal, 1999
- Up‐regulation of nitric oxide synthase by estradiol in human aorticendothelial cellsFEBS Letters, 1995